CENP-V As a Potential Diagnostic Marker of Damage in Human Oocytes

RecruitingOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

October 4, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Establish the Amount of CENPV Protein in Human Oocytes As a Diagnostic Tool Against Damage Caused by Ageing or by the Procedure of Vitrification of OocytesAdvance Maternal AgeVitrification and Thawing
Trial Locations (1)

41009

RECRUITING

Vida Recoletas Sevilla S.L., Seville

All Listed Sponsors
collaborator

University of Seville, Spain

UNKNOWN

lead

Vida Recoletas Sevilla

OTHER